Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case Series
The trial was registered with ClinicalTrials.gov with ID number NCT03346434 on November 17, 2017. Video abstract available for this article. Video abstract (MP4 1,02,609 KB).
Authors
- Ana B. Rossi (ORCID: https://orcid.org/0000-0001-5345-678X)
- Joseph Zahn
- Andréa F. Mello (ORCID: https://orcid.org/0000-0001-8498-7751)
Institutions
- Regeneron (United States) (US)
- Sanofi (United States) (US)
Publication Details
- Journal
- Advances in Therapy
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1007/s12325-025-03150-6
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Regeneron Pharmaceuticals